AVE Science & Technology Co

AVE Science & Technology Co Accounts Payable

The Accounts Payable of AVE Science & Technology Co (688067.SS) as of Nov 16, 2026 is 5.02 M CNY. In the previous year, Accounts Payable was 4.28 M CNY — a change of 17.12% (higher).

Accounts Payable

5.02 MCNY

YoY

17.12%

Last updated:

Accounts Payable of AVE Science & Technology Co is 2025 5.02 M CNY. Accounts Payable of AVE Science & Technology Co was 2024 4.28 M CNY. It decreases by 17.12% higher compared to the previous year.

The AVE Science & Technology Co Accounts Payable history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Accounts Payable
Date
Accounts Payable
Jan 1, 2018
4.15 M CNY
Jan 1, 2019
4.29 M CNY
Jan 1, 2020
7.74 M CNY
Jan 1, 2021
8.39 M CNY
Jan 1, 2022
8.27 M CNY
Jan 1, 2023
6.58 M CNY
Jan 1, 2024
4.28 M CNY
Jan 1, 2025
5.02 M CNY
The AVE Science & Technology Co Accounts Payable history
YEARAccounts PayableYoY
5.02 MCNY+17.12%
4.28 MCNY-34.89%
6.58 MCNY-20.39%
8.27 MCNY-1.43%
8.39 MCNY+8.31%
7.74 MCNY+80.30%
4.29 MCNY+3.49%
4.15 MCNY-1.77%
4.22 MCNY-21.45%
5.38 MCNY+171.05%
1.98 MCNY+4.49%
1.90 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

AVE Science & Technology Co Stock analysis

What does AVE Science & Technology Co do? AVE Science & Technology Co., Ltd. generates revenue through the research, development, production, sale, and service of clinical testing and analysis instruments. Its main products include urine formed component analyzer, urine dry chemistry analyzer, urine full item automatic analyzer, automatic stool analyzer, automatic body fluid analyzer, reproductive tract secretion analyzer, and special supporting in vitro diagnostic reagents and medical consumables. These products are primarily sold to inspection departments within medical and health institutions in both domestic and overseas markets. The company serves healthcare facilities that require diagnostic equipment for laboratory testing and patient care. The firm's product portfolio targets healthcare institutions seeking advanced diagnostic tools for efficient clinical analysis. By focusing on specialized instruments like urine and stool analyzers, AVE Science & Technology addresses specific needs in medical testing departments. The company's domestic and international distribution channels ensure broad market access for its diagnostic solutions. AVE Science & Technology's revenue streams are derived from the sale of its comprehensive range of clinical testing instruments and related consumables. The company's domestic market presence and overseas sales contribute to its overall business performance. Its products support routine diagnostic procedures across various healthcare settings, driving consistent demand for its equipment and reagents. AVE Science & Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AVE Science & Technology Co stock

Accounts Payable of AVE Science & Technology Co is 5.02 M CNY in 2025.

Accounts Payable of AVE Science & Technology Co changed from 4.28 M CNY to 5.02 M CNY, representing a 17.12% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Payable AVE Science & Technology Co since 2006 – with annual values, charts, and detailed analysis.

Accounts payable represents money owed to suppliers for goods and services received. It is a key component of working capital management.

Accounts Payable's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Payable's AVE Science & Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — AVE Science & Technology Co

All Key Metrics — AVE Science & Technology Co